molecule termed Toll receptor-IL-1 receptor domain-containing adpater protein (TIRAP) or MyD88 adapter-like protein (MAL) has recently been identified (9, 10) . Overexpression of TIRAP/MAL activates NF-B, and dominant negative mutants of the protein inhibit NF-B activation mediated by TLR (9, 10) . Dominant negative mutant of TIRAP/MAL blocks LPSinduced maturation of dendritic cells from both wild-type and MyD88-deficient mice (10) . Together, these data demonstrate that TIRAP/MAL is responsible for MyD88-independent TLR signaling.
In addition to NF-B activation, TLR can also activate MAPK signaling cascades. The MAPKs transduce extracellular signals into cellular responses and play important roles in cell proliferation, apoptosis, differentiation, cell migration, and gene expression (8, 32) . Mammalian cells express three types of MAPKs, including ERKs, p38 MAPKs, and c-Jun NH 2 -terminal kinases. Recent studies have shown that MAPKs, including ERK, c-Jun NH 2 -terminal kinases, and p38 can be activated by LPS. MAPKs p42 and p44, referred to as ERK1/ ERK2, are activated by MAPK/ERK kinase 1 (MEK1). The activation of p38 MAPK is regulated by upstream MAPKK (MKK3, MKK6, and probably MKK4) via phosphorylation of a TGY phosphorylation site (15, 24) . The p38 MAPK effects are carried out by downstream substrates, including protein kinases and transcription factors (20, 24) . Recently, the p38 MAPK signaling pathway has also been demonstrated to play an important role in regulating mRNA stability (13, 19, 31) . However, the role of TLRs in LTA-induced cell activation and TLR-mediated signaling events is not completely understood. It remains controversial whether LTA stimulates the immune system via TLR2 (5, 28) or TLR4 (30). Takeuchi et al. (30) have reported that LTA stimulates nitric oxide and cytokine IL-6 gene expression in macrophages from TLR2-deficient mice. In contrast, Schwandner et al. (29) suggested that LTA from a highly purified butanol-extracted procedure (22) stimulates NF-B activation via TLR2 (25) , and this function of LTA is enhanced by LBP and CD14 (28) .
LTA is the major component of the cell wall of grampositive bacteria and stimulates inflammatory responses in the lung (16, 18) . Therefore, understanding the mechanisms that regulate LTA-mediated cell activation is crucial for understanding the pathogenesis of lung inflammatory disease and the interactions between lung innate immunity and inflammatory responses. The report by Lee and coworkers, one of the current articles in focus (Ref. 14a, see p. L921 in this issue), provides further evidence that LTA (from the gram-positive bacteria Staphylococcus aureus)-stimulated MAPK activation is mediated through a TLR2 receptor and involves tyrosine kinase, PLC, PKC, Ca 2ϩ , and phosphatidylinositol 3-kinase in human tracheal smooth muscle cells. The authors demonstrated expression of both TLR2 and TLR4 receptor genes in human tracheal smooth muscle cells. Treatment of these cells with TLR2 antibody significantly blocked LTA-induced p42/p44 MAPK phosphorylation, but TLR4-blocking antibody had no effect on this response. Further demonstration of the require-ment of TLR2 for LTA-induced MAPK activation was obtained by overexpressing a human mutant of TLR2. The authors also transfected a human dominant mutant of TLR2 in human tracheal smooth muscle cells and found that LTAstimulated MAPK activity was blocked in these transfected cells. These data strongly suggest that LTA-activated MAPK is mediated through TLR2.
Lee and coworkers (14a) also examined the signaling molecules in TLR2-mediated MAPK activation stimulated with LTA. They provided evidence that tyrosine kinase, PLC, PKC, Ca 2ϩ , MEK, and phosphatidylinositol 3-kinase are important molecules in LTA-induced MAPK activation in human tracheal smooth muscle cells. Interestingly, although TLR2 by itself has no tyrosine kinase activity, it possesses several phosphotyrosine residues in the cytosolic domain. Arbibe et al. . In another study, it was reported that LPS-induced NF-B activation and cytokine gene expression utilize a signaling pathway requiring protein tyrosine kinase and that such regulation may occur through tyrosine phosphorylation of TLR4 (7). Thus it is possible that tyrosine phosphorylation of TLRs plays an important role in the activation of TLRs. The present experiments involve the use of genistein, a tyrosine kinase inhibitor. Further experiments might provide additional information of TLR activation, such as whether overexpressing a mutation of TLR2 (Tyr 616, 761 ) in human tracheal smooth muscle cells can abolish LTA-induced MAPK activation, or whether p85 subunit of phosphatidylinositol 3-kinase associates with tyrosinephosphorylated motifs on TLR2 in LTA-stimulated human tracheal smooth muscle cells (3) . Of particular interest, this paper contains data from the use of human primary airway cells in which the LTA-stimulated MAPK activation is mediated through a TLR2 receptor in human tracheal smooth muscle cells. Future studies are expected to address and delineate the relationship between MyD88, IRAKs, TRAF6, and TLR2, and the function of MyD88, IRAKs, and TRAF6 in LTA-induced MAPK activation in human tracheal smooth muscle cells.
